ArticleCardiovascular drugs and therapy2023

Trimetazidine to Reduce Myocardial Fibrosis-Competing Interests with SGLT2 Inhibitors?

Tyler B Moran et al.PubMed ↗Publisher ↗

No numbers read from the abstract.